TrialPsychopharmacology2019

Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.

Feikang Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.